Two doses of the Pfizer-BioNTech Covid-19 vaccine offer almost no protection against coronavirus infection in kids ages 5 to 11, according to new data posted online — a finding that may have consequences for parents and their vaccinated children.
Researchers from the New York State Department of Health found that the vaccine’s effectiveness dropped to 12 percent from 68 percent in the age group in December and January, when the omicron variant of the coronavirus began circulating widely in the United States.
Read more at:Pfizer Covid vaccine may not protect against infection in kids
Showing posts with label Pfizer. Show all posts
Showing posts with label Pfizer. Show all posts
Monday, February 28, 2022
Monday, September 20, 2021
Japan -Pfizer Vaccines: Contaminated Pfizer Vaccines Reported In Several Japanese Cities
Several cities in Japan have reported ‘white-colored floating substances’ in Vials of Pfizer’s Covid-19 vaccine, according to Bloomberg.
The vials came from lot FF5357, where white contaminants were first reported by Kamakura City in Kanagawa prefecture. On Tuesday, two more cities – neighboring Sagamihara and Sakai City in Osaka prefecture reported contaminated vials, however there were no reports of adverse reactions. In Sagamihara, white substances were reported at three different vaccination sites on Sept. 11, 12 and 14.
Read more at: Contaminated Pfizer Vaccines Reported In Several Japanese Cities
The vials came from lot FF5357, where white contaminants were first reported by Kamakura City in Kanagawa prefecture. On Tuesday, two more cities – neighboring Sagamihara and Sakai City in Osaka prefecture reported contaminated vials, however there were no reports of adverse reactions. In Sagamihara, white substances were reported at three different vaccination sites on Sept. 11, 12 and 14.
Read more at: Contaminated Pfizer Vaccines Reported In Several Japanese Cities
Tuesday, May 4, 2021
Coronavirus: Pfizer-BioNTech vaccine not troubled by variants so far, says CEO
One of the people behind the Pfizer-BioNTech COVID-19 vaccine says he has yet to see any evidence that emerging variants of the disease have found a way to defeat it.
Dr. Ugur Sahin, who founded BioNTech with his wife Dr. Özlem Türeci, told CBC News Network's Power & Politics today that scientists have two main concerns when it comes to variants of the COVID-19 virus.
Read more at: Pfizer-BioNTech vaccine not troubled by variants so far, says CEO | CBC News
Dr. Ugur Sahin, who founded BioNTech with his wife Dr. Özlem Türeci, told CBC News Network's Power & Politics today that scientists have two main concerns when it comes to variants of the COVID-19 virus.
Read more at: Pfizer-BioNTech vaccine not troubled by variants so far, says CEO | CBC News
Monday, November 9, 2020
Coronavirus vaccine : Our COVID-19 vaccine is 90% effective, says Pfizer - by Alice Tidey
A potential COVID-19 vaccine being developed by Pfizer and BioNTech has been found to be more than 90% effective.
The vaccine has been tested on more than 43,500 participants during Phase 3 — the final stage of development when it is given to thousands to test its efficacy and safety.
Analysis carried out evaluated that 94 trial participants had been confirmed to have contracted COVID-19.
"Today is a great day for science and humanity," Pfizer Chairman and CEO, Dr Albert Bourla, said in a statement.
Read more at: Coronavirus: Our COVID-19 vaccine is 90% effective, says Pfizer | Euronews
The vaccine has been tested on more than 43,500 participants during Phase 3 — the final stage of development when it is given to thousands to test its efficacy and safety.
Analysis carried out evaluated that 94 trial participants had been confirmed to have contracted COVID-19.
"Today is a great day for science and humanity," Pfizer Chairman and CEO, Dr Albert Bourla, said in a statement.
Read more at: Coronavirus: Our COVID-19 vaccine is 90% effective, says Pfizer | Euronews
Subscribe to:
Posts (Atom)